Neurocrine Biosciences | Capital Ordinaire



Ordinary Share Capital Changement Date
AbbVie USD 18M 0 2024-12
Acadia Pharmaceuticals USD 16K 0 2024-12
Agios Pharmaceuticals USD 74K 1000 2025-03
ALKERMES USD 1.8M 35K 2025-03
Alnylam Pharmaceuticals USD 1.3M 10K 2025-03
Amgen USD 33.58B 45M 2025-03
Biogen USD 100K 0 2024-12
BioMarin Pharmaceutical USD 192K 1000 2025-03
Cytokinetics USD 118K 0 2024-12
Dynavax Technologies USD 125K 6K 2024-12
Exelixis USD 282K 4K 2025-01
Gilead Sciences USD 1000K 0 2024-12
Halozyme Therapeutics USD 123K 4K 2024-12
Incyte USD 193K 0 2025-03
Ionis Pharmaceuticals USD 159K 1000 2025-03
Neurocrine Biosciences USD 100K 0 2024-12
Pfizer USD 480M 0 2024-12
Prothena USD 538K 0 2024-12
Regeneron Pharmaceuticals USD 0 102K 2025-03
Repligen USD 561K 1000 2024-12
Sarepta Therapeutics USD 10K 0 2024-12
Teva Pharmaceutical Industries USD 58M 0 2024-09
Ultragenyx Pharmaceutical USD 92K 0 2024-12
Vertex Pharmaceuticals USD 2.6M 0 2024-12



Neurocrine Biosciences Capital Ordinaire - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.